☆Affinity Asset Advisors, LLC
Quality Q
0.376
AUM ($M)
2,045
Positions
104
Turnover
0.22
Top-10 wt
43%
Herfindahl
0.027
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 114 positions · portfolio value $2,045M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆CUSIP:G76279101 funds › | ROIVANT SCIENCES LTD | ADD | — | 6.5% | +1.9% | 132.7 | 3,750,000 | +950,000 | 5 | — |
| ☆APGE funds › | APOGEE THERAPEUTICS INC | TRIM | — | 6.4% | +0.1% | 131.0 | 987,000 | -297,926 | 5 | — |
| ☆SYRE funds › | SPYRE THERAPEUTICS INC | HOLD | — | 5.6% | +1.8% | 113.6 | 1,279,134 | +0 | 5 | — |
| ☆XENE funds › | XENON PHARMACEUTICALS INC | TRIM | — | 4.7% | -1.0% | 96.3 | 1,595,000 | -80,000 | 5 | — |
| ☆ERAS funds › | ERASCA INC | TRIM | — | 4.7% | -0.4% | 96.2 | 5,250,000 | -100,000 | 5 | — |
| ☆INSM funds › | INSMED INC | ADD | — | 3.4% | -1.2% | 69.3 | 650,000 | +170,000 | 5 | — |
| ☆PRAX funds › | PRAXIS PRECISION MEDICINES I | ADD | — | 3.0% | -0.2% | 61.9 | 185,000 | +15,000 | 3 | — |
| ☆ALKS funds › | ALKERMES PLC | TRIM | — | 2.9% | +0.1% | 58.9 | 1,125,000 | -225,000 | 5 | — |
| ☆ORKA funds › | ORUKA THERAPEUTICS INC | ADD | — | 2.7% | +1.3% | 56.2 | 590,000 | +90,327 | 5 | — |
| ☆ANAB funds › | ANAPTYSBIO INC | TRIM | — | 2.7% | -0.3% | 55.8 | 826,109 | -113,891 | 3 | — |
| ☆AVTX funds › | AVALO THERAPEUTICS INC | ADD | — | 2.6% | +1.4% | 53.6 | 2,900,000 | +1,559,160 | 5 | — |
| ☆CYTK funds › | CYTOKINETICS INC | TRIM | — | 2.3% | -0.4% | 46.9 | 550,000 | -150,483 | 4 | — |
| ☆RVMD funds › | REVOLUTION MEDICINES INC | ADD | — | 2.3% | +1.7% | 46.8 | 250,000 | +150,000 | 4 | — |
| ☆ABVX funds › | ABIVAX SA | TRIM | — | 2.2% | -0.5% | 44.0 | 330,000 | -75,000 | 5 | — |
| ☆TRAX funds › | FIRST TRACKS BIOTHERAPEUTICS | NEW | — | 2.0% | +2.0% | 40.9 | 2,032,012 | +2,032,012 | 1 | — |
| ☆DNTH funds › | DIANTHUS THERAPEUTICS INC | ADD | — | 1.9% | +0.2% | 39.0 | 400,000 | +50,000 | 4 | — |
| ☆STRO funds › | SUTRO BIOPHARMA INC | ADD | — | 1.9% | +0.3% | 38.9 | 1,172,487 | +102,968 | 3 | — |
| ☆NUVL funds › | NUVALENT INC | TRIM | — | 1.7% | -0.1% | 34.0 | 275,000 | -25,000 | 5 | — |
| ☆TRVI funds › | TREVI THERAPEUTICS INC | TRIM | — | 1.6% | +0.2% | 33.6 | 1,800,172 | -200,000 | 5 | — |
| ☆OVID funds › | OVID THERAPEUTICS INC | TRIM | — | 1.3% | -0.1% | 27.3 | 10,144,562 | -491,756 | 5 | — |
| ☆LXEO funds › | LEXEO THERAPEUTICS INC | ADD | — | 1.3% | -0.4% | 27.0 | 5,807,611 | +757,400 | 5 | — |
| ☆CLDX funds › | CELLDEX THERAPEUTICS INC NEW | ADD | — | 1.3% | +0.3% | 26.0 | 700,000 | +200,000 | 4 | — |
| ☆BLTE funds › | BELITE BIO INC | ADD | — | 1.2% | +0.6% | 25.4 | 165,000 | +100,000 | 3 | — |
| ☆ELVN funds › | ENLIVEN THERAPEUTICS INC | TRIM | — | 1.2% | -0.1% | 25.4 | 500,000 | -86,904 | 2 | — |
| ☆FBRX funds › | FORTE BIOSCIENCES INC | ADD | — | 1.2% | -0.3% | 24.3 | 1,145,391 | +133,501 | 3 | — |
| ☆NRIX funds › | NURIX THERAPEUTICS INC | HOLD | — | 1.1% | +0.3% | 23.5 | 967,620 | +0 | 5 | — |
| ☆ANRO funds › | ALTO NEUROSCIENCE INC | ADD | — | 1.1% | +0.4% | 22.4 | 850,000 | +350,000 | 2 | — |
| ☆MDGL funds › | MADRIGAL PHARMACEUTICALS INC | TRIM | — | 1.1% | -0.6% | 21.5 | 40,000 | -15,000 | 5 | — |
| ☆PTGX funds › | PROTAGONIST THERAPEUTICS INC | HOLD | — | 1.0% | -0.0% | 21.1 | 172,125 | +0 | 5 | — |
| ☆MLYS funds › | MINERALYS THERAPEUTICS INC | HOLD | — | 1.0% | -0.2% | 20.2 | 750,000 | +0 | 5 | — |
| ☆RLAY funds › | RELAY THERAPEUTICS INC | ADD | — | 1.0% | +0.7% | 19.6 | 1,050,000 | +650,000 | 2 | — |
| ☆SGMT funds › | SAGIMET BIOSCIENCES INC | ADD | — | 0.9% | +0.7% | 19.3 | 2,497,864 | +1,629,844 | 4 | — |
| ☆JBIO funds › | JADE BIOSCIENCES INC | ADD | — | 0.9% | +0.4% | 18.7 | 840,350 | +200,394 | 5 | — |
| ☆COGT funds › | COGENT BIOSCIENCES INC | TRIM | — | 0.9% | -0.8% | 17.4 | 450,000 | -300,000 | 3 | — |
| ☆TVTX funds › | TRAVERE THERAPEUTICS INC | HOLD | — | 0.8% | +0.3% | 17.0 | 300,000 | +0 | 5 | — |
| ☆CGEM funds › | CULLINAN THERAPEUTICS INC | ADD | — | 0.8% | +0.1% | 15.9 | 875,760 | +94,500 | 5 | — |
| ☆SVRA funds › | SAVARA INC | HOLD | — | 0.8% | -0.0% | 15.5 | 2,512,153 | +0 | 5 | — |
| ☆IDYA funds › | IDEAYA BIOSCIENCES INC | NEW | — | 0.7% | +0.7% | 14.9 | 400,000 | +400,000 | 1 | — |
| ☆CATX funds › | PERSPECTIVE THERAPEUTICS INC | ADD | — | 0.7% | -0.1% | 14.4 | 4,214,582 | +1,050,000 | 5 | — |
| ☆ODTX funds › | ODYSSEY THERAPEUTICS INC | NEW | — | 0.7% | +0.7% | 14.3 | 766,346 | +766,346 | 1 | — |
| ☆CUSIP:19240QAA0 funds › | COGENT BIOSCIENCES INC | ADD | — | 0.7% | +0.2% | 13.7 | 11,000,000 | +4,000,000 | 3 | — |
| ☆HLXC funds › | HELIX ACQUISITION CORP III | HOLD | — | 0.7% | -0.1% | 13.3 | 1,250,000 | +0 | 2 | — |
| ☆EQ funds › | EQUILLIUM INC | ADD | — | 0.6% | +0.5% | 13.1 | 4,100,000 | +2,873,690 | 2 | — |
| ☆ESTA funds › | ESTABLISHMENT LABS HLDGS INC | ADD | — | 0.6% | +0.3% | 12.7 | 148,013 | +48,013 | 5 | — |
| ☆CLYM funds › | CLIMB BIO INC | ADD | — | 0.6% | +0.3% | 12.7 | 972,000 | +272,000 | 5 | — |
| ☆TEVA funds › | TEVA PHARMACEUTICAL INDS LTD | TRIM | — | 0.6% | -1.9% | 12.7 | 374,000 | -1,026,000 | 5 | — |
| ☆MANE funds › | VERADERMICS INC | ADD | — | 0.6% | +0.3% | 12.3 | 100,000 | +30,000 | 2 | — |
| ☆ARWR funds › | ARROWHEAD PHARMACEUTICALS IN | TRIM | — | 0.6% | -0.1% | 12.2 | 150,000 | -50,000 | 3 | — |
| ☆CUSIP:682143AK8 funds › | OMEROS CORP | HOLD | — | 0.6% | -0.2% | 12.2 | 6,525,000 | +0 | 5 | — |
| ☆TSHA funds › | TAYSHA GENE THERAPIES INC | ADD | — | 0.6% | +0.3% | 11.9 | 1,750,000 | +750,000 | 5 | — |
| ☆DMRA funds › | DAMORA THERAPEUTICS INC | TRIM | — | 0.5% | -0.1% | 11.1 | 425,000 | -25,000 | 2 | — |
| ☆EPRX funds › | EUPRAXIA PHARMACEUTICALS INC | ADD | — | 0.5% | -0.1% | 10.9 | 1,650,000 | +60,995 | 4 | — |
| ☆VERA funds › | VERA THERAPEUTICS INC | HOLD | — | 0.5% | -0.1% | 10.7 | 250,000 | +0 | 5 | — |
| ☆PRQR funds › | PROQR THRAPEUTICS N V | ADD | — | 0.5% | +0.3% | 10.3 | 5,543,936 | +3,089,658 | 5 | — |
| ☆NAMS funds › | NEWAMSTERDAM PHARMA COMPANY | HOLD | — | 0.5% | -0.1% | 9.3 | 275,000 | +0 | 5 | — |
| ☆KRRO funds › | KORRO BIO INC | HOLD | — | 0.5% | -0.0% | 9.3 | 706,904 | +0 | 2 | — |
| ☆AVR funds › | ANTERIS TECHNOLOGIES GLOBAL | HOLD | — | 0.4% | +0.1% | 9.0 | 912,397 | +0 | 5 | — |
| ☆ZURA funds › | ZURA BIO LTD | TRIM | — | 0.4% | -0.5% | 8.6 | 1,464,303 | -1,100,000 | 5 | — |
| ☆QURE funds › | UNIQURE NV | NEW | — | 0.4% | +0.4% | 8.1 | 175,000 | +175,000 | 1 | — |
| ☆ASND funds › | ASCENDIS PHARMA A/S | NEW | — | 0.4% | +0.4% | 8.0 | 30,000 | +30,000 | 1 | — |
| ☆IBIO funds › | IBIO INC | ADD | — | 0.3% | -0.0% | 7.0 | 4,007,881 | +900,681 | 3 | — |
| ☆GENB funds › | GENERATE BIOMEDICINES INC | ADD | — | 0.3% | +0.1% | 6.7 | 400,000 | +50,000 | 2 | — |
| ☆TYRA funds › | TYRA BIOSCIENCES INC | TRIM | — | 0.3% | -0.3% | 6.4 | 200,012 | -57,500 | 2 | — |
| ☆SLGL funds › | SOL-GEL TECHNOLOGIES LTD | ADD | — | 0.3% | +0.1% | 6.3 | 84,900 | +49,900 | 2 | — |
| ☆SABS funds › | SAB BIOTHERAPEUTICS INC | ADD | — | 0.3% | +0.2% | 5.9 | 1,525,000 | +950,000 | 2 | — |
| ☆MGNX funds › | MACROGENICS INC | ADD | — | 0.3% | +0.2% | 5.6 | 1,216,606 | +716,606 | 3 | — |
| ☆CRSP funds › | CRISPR THERAPEUTICS AG | TRIM | — | 0.3% | -0.2% | 5.5 | 100,000 | -50,000 | 2 | — |
| ☆CUSIP:N62509117 funds › | NEWAMSTERDAM PHARMA COMPANY | HOLD | — | 0.3% | -0.0% | 5.3 | 245,000 | +0 | 5 | — |
| ☆ASMB funds › | ASSEMBLY BIOSCIENCES INC | NEW | — | 0.3% | +0.3% | 5.2 | 190,000 | +190,000 | 1 | — |
| ☆RZLT funds › | REZOLUTE INC | TRIM | — | 0.3% | -0.0% | 5.2 | 1,000,000 | -547,641 | 5 | — |
| ☆DTIL funds › | PRECISION BIOSCIENCES INC | ADD | — | 0.2% | +0.1% | 5.1 | 646,576 | +48,630 | 2 | — |
| ☆COAG funds › | HEMAB THERAPEUTICS HLDGS INC | NEW | — | 0.2% | +0.2% | 5.1 | 138,030 | +138,030 | 1 | — |
| ☆VRDN funds › | VIRIDIAN THERAPEUTICS INC | HOLD | — | 0.2% | -0.1% | 4.6 | 250,000 | +0 | 5 | — |
| ☆AVBP funds › | ARRIVENT BIOPHARMA INC | TRIM | — | 0.2% | -0.0% | 4.3 | 125,000 | -50,000 | 3 | — |
| ☆VRCA funds › | VERRICA PHARMACEUTICALS INC | HOLD | — | 0.2% | -0.0% | 4.3 | 707,338 | +0 | 3 | — |
| ☆CMPS funds › | COMPASS PATHWAYS PLC | TRIM | — | 0.2% | -0.2% | 4.3 | 301,183 | -807,300 | 4 | — |
| ☆MBX funds › | MBX BIOSCIENCES INC | TRIM | — | 0.2% | -0.1% | 4.1 | 75,000 | -75,000 | 4 | — |
| ☆RACC funds › | RESEARCH ALLIANCE CORP III | NEW | — | 0.2% | +0.2% | 4.0 | 370,000 | +370,000 | 1 | — |
| ☆IMVT funds › | IMMUNOVANT INC | HOLD | — | 0.2% | +0.0% | 3.9 | 100,000 | +0 | 4 | — |
| ☆AMAN funds › | AMANAT ACQUISITION CORP | NEW | — | 0.2% | +0.2% | 3.8 | 375,000 | +375,000 | 1 | — |
| ☆BHVN funds › | BIOHAVEN LTD | NEW | — | 0.2% | +0.2% | 3.7 | 250,000 | +250,000 | 1 | — |
| ☆FTH funds › | FAETH THERAPEUTICS INC | NEW | — | 0.2% | +0.2% | 3.6 | 144,404 | +144,404 | 1 | — |
| ☆KPTI funds › | KARYOPHARM THERAPEUTICS INC | TRIM | — | 0.1% | -0.0% | 3.1 | 312,500 | -187,500 | 3 | — |
| ☆ALEC funds › | ALECTOR INC | ADD | — | 0.1% | +0.1% | 3.0 | 1,510,000 | +1,010,000 | 2 | — |
| ☆SGP funds › | SPYGLASS PHARMA INC | TRIM | — | 0.1% | -0.2% | 2.9 | 131,586 | -118,414 | 2 | — |
| ☆CRNX funds › | CRINETICS PHARMACEUTICALS IN | HOLD | — | 0.1% | -0.0% | 2.8 | 75,000 | +0 | 5 | — |
| ☆CUSIP:G6717R120 funds › | OAKTREE ACQUISITION CORP III | HOLD | — | 0.1% | -0.0% | 2.8 | 250,000 | +0 | 5 | — |
| ☆CUSIP:15102KAB6 funds › | CELCUITY INC | NEW | — | 0.1% | +0.1% | 2.3 | 2,000,000 | +2,000,000 | 1 | — |
| ☆JATT funds › | JATT II ACQUISITION CORP | NEW | — | 0.1% | +0.1% | 2.3 | 200,000 | +200,000 | 1 | — |
| ☆NMRA funds › | NEUMORA THERAPEUTICS INC. | NEW | — | 0.1% | +0.1% | 1.8 | 1,070,651 | +1,070,651 | 1 | — |
| ☆AMLX funds › | AMYLYX PHARMACEUTICALS INC | NEW | — | 0.1% | +0.1% | 1.8 | 98,999 | +98,999 | 1 | — |
| ☆ANL funds › | ADLAI NORTYE LTD | TRIM | — | 0.1% | +0.0% | 1.8 | 153,847 | -10,901 | 2 | — |
| ☆SPRB funds › | SPRUCE BIOSCIENCES INC | NEW | — | 0.1% | +0.1% | 1.6 | 30,000 | +30,000 | 1 | — |
| ☆EIKN funds › | EIKON THERAPEUTICS INC | NEW | — | 0.1% | +0.1% | 1.3 | 98,001 | +98,001 | 1 | — |
| ☆OKUR funds › | ONKURE THERAPEUTICS INC | HOLD | — | 0.1% | -0.0% | 1.1 | 240,963 | +0 | 2 | — |
| ☆ENGN funds › | ENGENE THERAPEUTICS INC | NEW | — | 0.1% | +0.1% | 1.0 | 600,000 | +600,000 | 1 | — |
| ☆XFOR funds › | X4 PHARMACEUTICALS INC | HOLD | — | 0.0% | -0.0% | 0.7 | 145,000 | +0 | 3 | — |
| ☆BOLD funds › | BOUNDLESS BIO INC | NEW | — | 0.0% | +0.0% | 0.6 | 250,000 | +250,000 | 1 | — |
| ☆LENZ funds › | LENZ THERAPEUTICS INC | HOLD | — | 0.0% | -0.0% | 0.6 | 100,000 | +0 | 2 | — |
| ☆QTTB funds › | Q32 BIO INC | HOLD | — | 0.0% | +0.0% | 0.4 | 27,777 | +0 | 5 | — |
| ☆OBIO funds › | ORCHESTRA BIOMED HLDGS INC | TRIM | — | 0.0% | -0.1% | 0.1 | 33,400 | -369,150 | 4 | — |
| ☆NXTC funds › | NEXTCURE INC | TRIM | — | 0.0% | -0.1% | 0.1 | 41,960 | -199,866 | 4 | — |
| ☆ADGM funds › | ADAGIO MED HLDGS INC | HOLD | — | 0.0% | -0.0% | 0.1 | 80,000 | +0 | 5 | — |
| ☆RCKTW funds › | ROCKET PHARMACEUTICALS INC | HOLD | — | 0.0% | -0.0% | 0.0 | 75,000 | +0 | 5 | — |
| ☆CUSIP:15102KAA8 funds › | CELCUITY INC | EXIT | — | 0.0% | -0.4% | 0.0 | 0 | -3,000,000 | 0 | — |
| ☆CUSIP:29286M105 funds › | ENGENE HOLDINGS INC | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -610,370 | 0 | — |
| ☆CUSIP:03940C100 funds › | ARCELLX INC | EXIT | — | 0.0% | -2.4% | 0.0 | 0 | -362,764 | 0 | — |
| ☆CUSIP:152309100 funds › | CENTESSA PHARMACEUTICALS PLC | EXIT | — | 0.0% | -3.3% | 0.0 | 0 | -1,400,000 | 0 | — |
| ☆CUSIP:880881107 funds › | TERNS PHARMACEUTICALS INC | EXIT | — | 0.0% | -1.7% | 0.0 | 0 | -562,631 | 0 | — |
| ☆CORT funds › | CORCEPT THERAPEUTICS INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -50,000 | 0 | — |
| ☆CUSIP:49372L209 funds › | KEZAR LIFE SCIENCES INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -229,076 | 0 | — |
| ☆BBIO funds › | BRIDGEBIO PHARMA INC | EXIT | — | 0.0% | -0.7% | 0.0 | 0 | -150,000 | 0 | — |
| ☆WVE funds › | WAVE LIFE SCIENCES LTD | EXIT | — | 0.0% | -0.6% | 0.0 | 0 | -1,401,727 | 0 | — |
| ☆CUSIP:04351P101 funds › | ASCENDIS PHARMA A/S | EXIT | — | 0.0% | -1.3% | 0.0 | 0 | -95,000 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 2,045 | 104 | 0.22 | 43% | 0.027 | 0.373 | — | in |
| 2026Q1 | 1,705 | 95 | 0.28 | 42% | 0.027 | 0.268 | — | in |
| 2025Q4 | 1,392 | 86 | 0.38 | 43% | 0.027 | 0.093 | — | in |
| 2025Q3 | 1,075 | 86 | 0.29 | 45% | 0.030 | 0.179 | — | in |
| 2025Q2 | 676 | 77 | 0.26 | 51% | 0.035 | 0.246 | — | entered |
| 2025Q1 | 639 | 81 | 0.00 | 50% | 0.034 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status